ABSTRACT: BACKGROUND Panic disorder (PD) is a disabling psychiatry condition that affects approximately 5% of the worldwide population. Currently, long-term selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for PD; however, the common side-effect profiles and drug interactions may provoke patients to abandon the treatment, leading to PD symptoms ... Continue Reading
Health Condition
STUDY: Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
ABSTRACT: Multiple cannabinoids derived from the marijuana plant have potential therapeutic benefits but most have not been well investigated, despite the widespread legalization of medical marijuana in the USA and other countries. Therapeutic indications will depend on determinations as to which of the multiple cannabinoids, and other biologically active chemicals that are ... Continue Reading
STUDY: Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
ABSTRACT: Background Cervical cancer remains a global health related issue among females of Sub-Saharan Africa, with over half a million new cases reported each year. Different therapeutic regimens have been suggested in various regions of Africa, however, over a quarter of a million women die of cervical cancer, annually. This makes it the most lethal cancer amongst black ... Continue Reading
CBD Reduced Seizures in Epileptic Children by 40%
A CBD-based treatment for LGS patients, including children, was shown to decrease seizures by about 40%. This post from Futurism shares more details of the CBD study. IN BRIEF A clinical study showed that a cannabis-based medication could benefit patients, including children, who suffer from a type of epilepsy known as LGS. The results showed that LGS patients who ... Continue Reading
STUDY: Why do cannabinoid receptors have more than one endogenous ligand?
ABSTRACT: The endocannabinoid system was revealed following the understanding of the mechanism of action of marijuana's major psychotropic principle, Δ9-tetrahydrocannabinol, and includes two G-protein-coupled receptors (GPCRs; the cannabinoid CB1 and CB2 receptors), their endogenous ligands (the endocannabinoids, the best studied of which are anandamide and ... Continue Reading